✎ About Alan Auerbach

Alan Auerbach was born in United States. Alan Auerbach has scored two big successes in the risky biotech sector. Johnson & Johnson paid about $1 billion in cash in 2009 for his first cancer drug company, Cougar Biotechnology; he netted an estimated $50 million in that transaction. Shares of his latest business, Puma Biotechnology, soared in mid 2014 following good news from a late stage clinical trial of breast cancer drug neratinib, which Puma had licensed from Pfizer. Auerbach, who got through college on a mix of scholarships, fellowships and working part-time jobs, has a bachelors and a master's degree in biomedical engineering. He started his career as a research analyst covering biotech companies from Los Angeles, where Puma Biotechnology is based.
Alan Auerbach is a member of Medicine

💰Alan Auerbach Net worth: $1.2 Billion

2014 $1.55 Million

2015 $1.2 Million

2018 $1.2 Million

Some Alan Auerbach images

Biography/Timeline

1992

Auerbach is a fellow of the American Academy of Arts and Sciences and of the Econometric Society. He was the Deputy Chief of Staff of the U.S. Join Committee on Taxation in 1992.

Tags:

Alan Auerbach fans also viewed:

Gayle Cook Net Worth
Medicine

Jeanine Dick Net Worth
Medicine

Alan Auerbach Net Worth
Medicine

G.V. Prasad Net Worth
Medicine